Efficacy and Safety Outcomes of Optometrist Performed Selective Laser Trabeculoplasty (SLT) (SLT)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
Participants will undergo a pre-procedure examination in order to record baseline findings and to determine if they meet the inclusion criteria in order to undergo the procedure. Participants will undergo the SLT procedure and will be examined at 1 hour, 1 week and 6 weeks. Follow up examinations will evaluate eye pressure reduction and post-procedure complications. The rate complication post-procedure are typically low.
Intraocular Pressure via Goldmann tonometry [ Time Frame: 6 weeks ]
Pre and Post Procedure Intraocular Pressure will be measured using a Goldmann tonometer and will be measured in millimeters of Mercury (mmHg). Percent change in intraocular pressure will be determined.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Existing patients at primary eye care optometric facilities.
Ability to provide written informed consent;
At least 18 years of age, male or female, of Native American or Alaskan Native descent;
Diagnosed with primary open angle glaucoma or ocular hypertension;
Documented intraocular pressure greater than or equal to 23 mmHg;
No prior glaucoma treatment unless treated with one topical drop.
History of trauma or ocular surgery within the last 6 months;
History of corneal dystrophy;
Current use of topical or systemic steroids;
Advanced or severe glaucomatous findings based on comprehensive examination;
Diagnosed with other types of glaucoma such as pseudoexfoliation syndrome, pigmentary glaucoma, normal tension glaucoma, and other additional glaucoma subtypes.